Zobrazeno 1 - 10
of 57
pro vyhledávání: '"H. P. Niendorf"'
Autor:
J Haustein, T Louton, J. Planitzer, M. F. Reiser, Wolfgang Schörner, M Schöffel, Michael Laniado, Beck W, W Kaiser, H P Niendorf
Publikováno v:
Radiology. 186:855-860
To investigate the safety, patient tolerance, and efficacy with 0.3 mmol/kg gadopentetate dimeglumine in magnetic resonance (MR) imaging of the central nervous system (CNS), a phase 3 trial was conducted in 199 patients with suspected CNS lesions. Pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e586205ab3d250a8663d7c5ad3d4fc7
https://doi.org/10.1148/radiology.186.3.8430199
https://doi.org/10.1148/radiology.186.3.8430199
Autor:
H. P. Niendorf
Publikováno v:
European Radiology. 6:S8-S10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12751e7a3262969c7393fcaf66897d47
https://doi.org/10.1007/bf02484456
https://doi.org/10.1007/bf02484456
Autor:
W. Semmler, G. Brix, H. Kolem, W. R. Nitz, M. Bock, F. Hauert, H. Fischer, H. P. Niendorf, T. Balzer, P. Reimer
Publikováno v:
Magnetresonanztomographie ISBN: 9783642630767
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76169c31ec2d0b7f9b3b75494d62e7eb
https://doi.org/10.1007/978-3-642-56044-6_2
https://doi.org/10.1007/978-3-642-56044-6_2
Publikováno v:
Contrast Media in Practice ISBN: 9783540647591
A major feature of magnetic resonance imaging (MRI) is the great variation possible in the choice of suitable scanning sequences to obtain optimal image contrast and the desired tissue differentiation. As with any other procedure, the sensitivity and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6b59d872e9c73cdc1e2694ba21a8e97
https://doi.org/10.1007/978-3-642-59957-6_10
https://doi.org/10.1007/978-3-642-59957-6_10
Autor:
H P, Niendorf, R C, Brasch
Publikováno v:
Rontgenpraxis; Zeitschrift fur radiologische Technik. 50(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e8716007769613d1dd37d20156107e80
https://pubmed.ncbi.nlm.nih.gov/9492559
https://pubmed.ncbi.nlm.nih.gov/9492559
Publikováno v:
Magnetresonanztomographie ISBN: 9783642979637
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5e904834a6a576142c981f4c11fe998
https://doi.org/10.1007/978-3-642-97962-0_2
https://doi.org/10.1007/978-3-642-97962-0_2
Publikováno v:
Annals of the Academy of Medicine, Singapore. 22(5)
The development of reproducible echogenic contrast agents, which contain physiologically degradable acoustic strays in micrometre dimensions, has been under way for several years; all currently known industrial echocontrast agents are based on microb
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::422cfc90918f2460c8b022741450b4d9
https://pubmed.ncbi.nlm.nih.gov/8267359
https://pubmed.ncbi.nlm.nih.gov/8267359
Publikováno v:
Kontrastmittel in der Praxis ISBN: 9783540566144
Als KM fur die MRT sind am ehesten Substanzen geeignet, die die Relaxationszeiten der darzustellenden anatomischen Strukturen verandern. Fur diesen Zweck sind sowohl paramagnetische als auch superparamagnetische Stoffe geeignet. Die im feldfreien Rau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31e23a0013800dd191439fb9aa15e8ba
https://doi.org/10.1007/978-3-642-93540-4_10
https://doi.org/10.1007/978-3-642-93540-4_10
Publikováno v:
Contrast Media in Practice ISBN: 9783540571872
The substances most suitable as CM for MRI are those that change the relaxation times of the anatomic structures to be depicted. Both paramagnetic and superparamagnetic substances are appropriate for this purpose. The magnetic moments of the individu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::911b1300db28002efa407ef9865802ab
https://doi.org/10.1007/978-3-642-97530-1_10
https://doi.org/10.1007/978-3-642-97530-1_10
Publikováno v:
AJNR Am J Neuroradiol
PURPOSE: To investigate the efficacy of 0.025, 0.05 and 0.1 mmol/kg gadopentetate dimeglumine in MR imaging of patients with intracranial tumors at mid and high field strength. METHODS: In 88 patients, an open-label phase III multicenter dose-finding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f8c6ab0dd9a23985b2649e723a79393b
https://pubmed.ncbi.nlm.nih.gov/1636537
https://pubmed.ncbi.nlm.nih.gov/1636537